The global contrast-enhanced ultrasound industry is on the brink of remarkable expansion, as revealed by recent reports citing a substantial surge from an anticipated valuation of US$ 2,700 million in 2022 to an estimated US$ 5,243.3 million in 2023. This growth trajectory is a testament to the immediate escalation in the number of lung ultrasonography procedures, driving the demand for this innovative medical process.
According to insights from Future Market Insights, the contrast-enhanced ultrasound sector is set to chart a compelling course, expanding at a robust Compound Annual Growth Rate (CAGR) of 5.8% between 2023 and 2033. This trajectory indicates a promising leap, projecting a valuation of approximately US$ 9,214.3 million by the year 2033.
Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-10031
The rise in demand for contrast-enhanced ultrasound procedures mirrors the evolving landscape of medical diagnostics, particularly in lung ultrasonography, where the technology is demonstrating significant efficacy and adoption. This surge underscores the growing confidence among healthcare professionals in leveraging this advanced imaging technique for accurate and non-invasive diagnostics.
“The projected growth of the contrast-enhanced ultrasound market reaffirms its pivotal role in modern medical diagnostics,” stated Future Market Insights. “The burgeoning demand for this technology, especially in lung ultrasonography, underscores its efficacy and the confidence healthcare providers place in its diagnostic capabilities.”
The anticipated growth also aligns with the increasing emphasis on non-invasive imaging techniques, indicative of the market’s potential to meet evolving healthcare needs worldwide. The predicted valuation reflects the market’s readiness to offer innovative solutions, potentially reshaping the landscape of diagnostic imaging over the next decade.
Key Takeaways from the Market Study:
- Global contrast-enhanced ultrasound industry grew at a CAGR of 4.7% between 2017 and 2022
- Value of global contrast-enhanced ultrasound industry in 2017 was US$ 2,146.0 million
- North America dominates the market and is expected to continue its stronghold for a few more years with a market share of 36.0%, where the United States is expected to hold a major share in the market of 52.4%.
- Japan shares a value of 7.4%. Prospering medical tourism in developing countries such as India growing at a CAGR of 6.9%, Australia at a CAGR of 5.2%, and the Chinese market at 7.7% which further boosts the demand for world-class healthcare services.
- Europe holds a market share of 28.0% whereas the United Kingdom and Germany are said to hold an important part in this region where Germany holds a market share of 7.0% and the United Kingdom is said to grow at a CAGR of 5.1%.
- Targeted type holds a major portion of the market and holds a market share of 59.0%
- Hospitals are said to dominate the market and are projected for a revenue share of 39%
- Demand for echocardiography is said to be faring where echocardiography shares a major portion of the market with a value of 60.13%
“Immediate Increase in the Number of Lung Ultrasonography Procedures is one of the major drivers of the Contrast-Enhanced Ultrasound Market”, comments a Future Market Insights Analyst
Get the information you need by connecting with our analyst today! https://www.futuremarketinsights.com/ask-question/rep-gb-10031
Competitive Analysis:
Some of the prominent players in the global market are-
- Trivitron Healthcare
- Bracco Diagnostic Inc.
- Koninklijke Philips N.V.
- K. Medical Holding Company, Inc.
- Lantheus Medical Imaging, Inc.
- GE Healthcare
- Daiichi Sankyo Company, Limited
- Bristol-Myers Squibb Company
- Acusphere, Inc.
- Siemens Healthcare GmbH
Some of the important developments of the key players in the market are:
- In June 2023, Acusphere, Inc. announced the signing of a definitive agreement with Cephalon, Inc. to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an exclusive worldwide license to AI-525, a preclinical-stage injectable formulation of celecoxib using Acusphere’s proprietary Hydrophobic Drug Delivery System (HDDSTM) technology.
- In April 2023, Bracco Imaging S.p.A., a global leader in diagnostic imaging, and SonoThera, Inc., a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, have entered into an agreement under which Bracco Imaging will provide its cutting-edge gas-filled microbubbles technology platform to SonoThera for use in the development of its novel, ultrasound-guided nonviral gene therapy platform.
Personalized Solutions for Every Industry: Discover More in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-10031
Key Segments Profiled in the Contrast-Enhanced Ultrasound Industry Survey:
Type:
- Non-Targeted
- Targeted
Application:
- Hepatic
- Echocardiography
- Cerebrovascular
- Thyroid & Parathyroid
- Gallbladder & Biliary Tree
- Renal
- Prostate
- Pancreatic
- Vascular
- Lymphatic
- Trauma
- Others
Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
